BioCentury | Aug 1, 2020
Product Development

July 31 Quick Takes: FDA approves MorphoSys’ tafasitamab; Truvian, AbbVie, Boehringer, Lilly, Alector, Henlius-Accord, Ascletis, Roche, Merck

...Nets $900M Up Front in Global Deal with Incyte” ). Truvian serology test receives EUA Truvian Sciences Inc....
...Ingelheim GmbH AbbVie Inc. Eli Lilly and Co. Mirati Therapeutics Inc. Amgen Inc. Merck & Co. U.S. Food and Drug Administration (FDA) Truvian Sciences Inc. Ascletis...
Items per page:
1 - 1 of 1
BioCentury | Aug 1, 2020
Product Development

July 31 Quick Takes: FDA approves MorphoSys’ tafasitamab; Truvian, AbbVie, Boehringer, Lilly, Alector, Henlius-Accord, Ascletis, Roche, Merck

...Nets $900M Up Front in Global Deal with Incyte” ). Truvian serology test receives EUA Truvian Sciences Inc....
...Ingelheim GmbH AbbVie Inc. Eli Lilly and Co. Mirati Therapeutics Inc. Amgen Inc. Merck & Co. U.S. Food and Drug Administration (FDA) Truvian Sciences Inc. Ascletis...
Items per page:
1 - 1 of 1